Hathcock et al. demonstrated that systemic abrogation of ATM promotes the development of B-cell lymphoma in mice lacking T cells and that the NF-κB-pathway was significantly enhanced in these lymphoma cells38. Here, ATM is linked to B-cell non-Hodgkin lymphoma.